AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 100 filers reported holding AVANIR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $18,850,000 | +62.4% | 1,112,115 | +14.2% | 0.01% | +37.5% |
| Q3 2014 | $11,608,000 | +133.8% | 973,951 | +10.6% | 0.01% | +166.7% |
| Q2 2014 | $4,964,000 | +75.3% | 880,233 | +14.0% | 0.00% | +50.0% |
| Q1 2014 | $2,832,000 | +19.8% | 771,892 | +9.7% | 0.00% | 0.0% |
| Q4 2013 | $2,363,000 | -16.4% | 703,457 | +5.5% | 0.00% | 0.0% |
| Q3 2013 | $2,826,000 | +1.5% | 666,596 | +10.1% | 0.00% | 0.0% |
| Q2 2013 | $2,784,000 | – | 605,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $918,000 | 0.42% |
| Baker Brothers Advisors | 5,790,139 | $21,250,000 | 0.27% |
| Rock Springs Capital Management LP | 300,000 | $1,101,000 | 0.25% |
| J. Goldman & Co LP | 700,000 | $2,569,000 | 0.19% |
| Artal Group S.A. | 1,300,000 | $4,771,000 | 0.17% |
| Artal Group S.A. | 900,000 | $3,303,000 | 0.12% |
| FRANKLIN STREET ADVISORS INC /NC | 130,000 | $477,000 | 0.10% |
| Lyons Wealth Management, LLC. | 29,340 | $108,000 | 0.09% |
| TimesSquare Capital Management, LLC | 4,195,678 | $15,398,000 | 0.08% |
| LMR Partners LLP | 107,955 | $396,000 | 0.06% |